Indole amide hydroxamic acids as potent inhibitors of histone deacetylases

被引：51

作者：

Dai, YJ ^{[1
]}

Guo, Y ^{[1
]}

Guo, J ^{[1
]}

Pease, LJ ^{[1
]}

Li, JL ^{[1
]}

Marcotte, PA ^{[1
]}

Glaser, KB ^{[1
]}

Tapang, P ^{[1
]}

Albert, DH ^{[1
]}

Richardson, PL ^{[1
]}

Davidsen, SK ^{[1
]}

Michaelides, MR ^{[1
]}

机构：

[1] Abbott Labs, Canc Res, Dept R47J, Abbott Pk, IL 60064 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2003年 / 13卷 / 11期

关键词：

D O I：

10.1016/S0960-894X(03)00301-9

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of hydroxamic acid-based HDAC inhibitors with an indole amide residue at the terminus have been synthesized and evaluated. Compounds with a 2-indole amide moiety have been found as the most active inhibitors among the different regioisomers. Introduction of substituents on the indole ring further improved the potency and generated a series of very potent inhibitors with significant antiproliferative activity. A representative compound in the series, 7b, has been found to be orally active in tumor growth inhibition model. (C) 2003 Elsevier Science Ltd. All rights reserved.

引用

页码：1897 / 1901

页数：5

共 20 条

[11] Synthesis of apicidin-derived quinolone derivatives: Parasite-selective histone deacetylase inhibitors and antiproliferative agents [J].

Meinke, PT ;

Colletti, SL ;

Doss, G ;

Myers, RW ;

Gurnett, AM ;

Dulski, PM ;

Darkin-Rattray, SJ ;

Allocco, JJ ;

Galuska, S ;

Schmatz, DM ;

Wyvratt, MJ ;

Fisher, MH .

JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (25) :4919-4922

[12] Inhibitors of human histone deacetylase: Synthesis and enzyme and cellular activity of straight chain hydroxamates [J].

Remiszewski, SW ;

Sambucetti, LC ;

Atadja, P ;

Bair, KW ;

Cornell, WD ;

Green, MA ;

Howell, KL ;

Jung, M ;

Kwon, P ;

Trogani, N ;

Walker, H .

JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) :753-757

[13] A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors [J].

Saito, A ;

Yamashita, T ;

Mariko, Y ;

Nosaka, Y ;

Tsuchiya, K ;

Ando, T ;

Suzuki, T ;

Tsuruo, T ;

Nakanishi, O .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4592-4597

[14] Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects [J].

Sambucetti, LC ;

Fischer, DD ;

Zabludoff, S ;

Kwon, PO ;

Chamberlin, H ;

Trogani, N ;

Xu, H ;

Cohen, D .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (49) :34940-34947

[15] Role of covalent modifications of histones in regulating gene expression [J].

Spencer, VA ;

Davie, JR .

GENE, 1999, 240 (01) :1-12

[16] Synthesis of 7200 small molecules based on a substructural analysis of the histone deacetylase inhibitors trichostatin and trapoxin [J].

Sternson, SM ;

Wong, JC ;

Grozinger, CM ;

Schreiber, SL .

ORGANIC LETTERS, 2001, 3 (26) :4239-4242

[17] Histone deacetylase inhibitors in cancer treatment [J].

Vigushin, DM ;

Coombes, RC .

ANTI-CANCER DRUGS, 2002, 13 (01) :1-13

[18] Structure-activity relationships on phenylalanine-containing inhibitors of histone deacetylase:: In vitro enzyme inhibition, induction of differentiation, and inhibition of proliferation in friend leukemic cells [J].

Wittich, S ;

Scherf, H ;

Xie, CP ;

Brosch, G ;

Loidl, P ;

Gerhäuser, C ;

Jung, M .

JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (15) :3296-3309

[19] Structurally simple trichostatin A-like straight chain hydroxamates as potent histone deacetylase inhibitors [J].

Woo, SH ;

Frechette, S ;

Abou Khalil, E ;

Bouchain, G ;

Vaisburg, A ;

Bernstein, N ;

Moradei, O ;

Leit, S ;

Allan, M ;

Fournel, M ;

Trachy-Bourget, MC ;

Li, ZM ;

Besterman, JM ;

Delorme, D .

JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (13) :2877-2885

[20]

YOSHIDA M, 1990, J BIOL CHEM, V265, P17174

← 1 2 →